1. Clinical pharmacokinetics of atenolol — A review

   • W. Kirch
   • K. G. Görg

   ReviewPaper Pages: 81 - 91

2. Antileptazol activity and kinetic of CP 1414 S (7-nitro-2-amino-5-phenyl-3-H-, 1,5-benzodiazepine-4-one) in the rat and mouse

   • Caccia S.
   • Ballabio M.
   • Samanin R.

   OriginalPaper Pages: 93 - 97

3. Pharmacokinetic studies of flumecinol in man and dog

   • I. Klebovich
   • L. Vereczkey
   • I. Bodrogligeti

   OriginalPaper Pages: 99 - 104

4. Single dose pharmacokinetics of fendiline in humans

   • W. R. Kukovetz
   • F. Brunner
   • D. Mayer

   OriginalPaper Pages: 105 - 110

5. Isolation and mass spectrometric identification of gitoxin metabolites excreted in bile

   • L. N. Kadima
   • G. Lhoest
   • M. Lesne

   OriginalPaper Pages: 111 - 117

6. First pass effect of pinazepam in the rabbit liver

   • G. M. Pacifici
   • G. F. Placidi

   OriginalPaper Pages: 119 - 122

7. Pharmacokinetics of doxycycline polyphosphate after oral multiple dosing in humans

   • Saux M. C.
   • Mosser J.
   • Leng B.

   OriginalPaper Pages: 123 - 130

8. Identification of biliary metabolites of Mebendazole in the rat

   • R. J. Allan
   • T. R. Watson

   OriginalPaper Pages: 131 - 136

9. Stereochemical characterization of interactions of chiral 1,4-benzodiazepine-2-ones with liver microsomes

   • Slobodan Rendic
   • Franjo Kajfez

   OriginalPaper Pages: 137 - 146

10. Febarbamate: Metabolism in the rat

    • Jindrich Vachta
    • Philippe Gold-Aubert

    OriginalPaper Pages: 147 - 156

11. Testing for toxicity Edited by J.W. Gorrod

    New Book Pages: 157 - 157

12. Erratum to: Enterohepatic circulation in rat and dog of¹⁴C-0-[3-(4-<2-methoxyphenyl>-1-pipera zinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it’s demethylated metabolite

    • H. Paul
    • A. Illing
    • Esther S. A. House

    Erratum Pages: 158 - 158